サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1335881

デジタル用量吸入器の世界市場規模、シェア、産業動向分析レポート：製品別（定量吸入器（MDI）、乾燥粉末吸入器（DPI））、タイプ別、適応症別（COPD、喘息、その他）、地域別展望・予測、2023年～2030年

Global Digital Dose Inhaler Market Size, Share & Industry Trends Analysis Report By Product (Metered Dose Inhaler (MDI), and Dry Powder Inhaler (DPI)), By Type, By Indication (COPD, Asthma, and Others), By Regional Outlook and Forecast, 2023 - 2030

出版日
発行
KBV Research
ページ情報
英文 230 Pages
納期
即納可能 即納可能とは
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=143.57円
デジタル用量吸入器の世界市場規模、シェア、産業動向分析レポート：製品別（定量吸入器（MDI）、乾燥粉末吸入器（DPI））、タイプ別、適応症別（COPD、喘息、その他）、地域別展望・予測、2023年～2030年
出版日: 2023年07月31日
発行: KBV Research
ページ情報: 英文 230 Pages
納期: 即納可能 即納可能とは
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

デジタル用量吸入器市場規模は、2030年までに490億米ドルに達すると予測され、予測期間中のCAGRは19.6%の市場成長率で上昇します。

さらに、感染者のケアを提供するために、医療用品の需要が高まっています。噴霧器、酸素発生器、生命維持装置、モニターなどの呼吸支援機器は、一次医療で最も頻繁に使用される医療機器の一部です。COVID-19パンデミックの継続的な発生は、医療機器産業に好影響を与えました。それはデジタル線量吸入の市場に影響を与えます。しかし、このパンデミックの拡大はサプライチェーンに影響を与え、デジタル用量吸入デバイスの需要を減少させ、その結果、多くの地域で産業の一時的な停止や政府によるロックダウンの発表につながっています。

さらに、患者データのセキュリティに対する懸念から、市場の拡大は緩やかなものになると予測されています。COPDや喘息の症状に関する知識が不足しているため、呼吸器疾患を持つ人の大多数は診断されず、その結果、誤った治療を受けています。これは、患者が技術に精通していないことと、支払い制限の結果かもしれないです。デバイスの入手可能性が限られていることも、現在の状況を考えると、予測期間を通じてデジタル用量吸入器市場にマイナスの影響を与える問題です。

製品展望

製品に基づき、市場は定量吸入器（MDI）と乾燥粉末吸入器（DPI）に区分されます。2022年には、定量吸入器（MDI）セグメントが市場で最も高い収益シェアを占めました。これはヘルスケアコストの上昇と呼吸器疾患患者の増加によるものです。さらに、力学的薬物動態/薬力学（PK/PD）モデリングや、少量で高薬物量を送達するナノテクノロジーに基づく製剤など、吸入薬の開拓に関連する一貫した技術進歩は、薬の治療効果を高め、市場全体に影響を与える重要な要因の一部です。

タイプ別展望

タイプ別では、市場はブランド薬とジェネリック薬に細分化されます。ジェネリック医薬品セグメントは市場で最も高い収益シェアを獲得しています。デジタル吸入器には、薬の使用状況を監視・追跡するセンサーや接続機能が含まれていることが多いです。デジタル吸入器は吸入器の使用日、時間、頻度を記録することができ、患者、ヘルスケアプロバイダー、研究者に貴重な情報を提供します。いくつかのデジタル吸入器は、服薬リマインダーやアラートをプログラムすることができます。

適応症の展望

適応症別では、市場は喘息、慢性閉塞性肺疾患（COPD）、その他に二分されます。2022年には、慢性閉塞性肺疾患（COPD）セグメントが市場を独占しました。COPD罹患率の世界の増加により、予測期間中、このセグメントが優位を占めると予測されます。タバコの使用、大気汚染、花粉、化学物質の蒸気、小児期の感染症はすべてCOPDの原因です。デジタル用量吸入器は、COPD患者が呼吸器系の健康状態や薬剤アドヒアランスをモニタリングするのを支援し、より効果的に病気を管理できるようにします。

地域別展望

地域別では、市場は北米、欧州、アジア太平洋、LAMEAで分析されます。2022年には、北米地域が最も高い収益シェアを獲得して市場をリードしました。この背景には、徹底した研究開発努力と、現在利用可能なハイテク呼吸器に対する認知度の向上があります。さらに、子供や高齢者の呼吸器疾患の有病率の増加が、予測期間中の市場拡大を促進します。

目次

第1章 市場範囲と調査手法

  • 市場の定義
  • 目的
  • 市場範囲
  • セグメンテーション
  • 調査手法

第2章 市場の概要

  • 主なハイライト

第3章 市場概要

  • イントロダクション
    • 概要
      • 市場構成とシナリオ
  • 市場に影響を与える主な要因
    • 市場促進要因
    • 市場抑制要因
  • ポーターのファイブフォース分析

第4章 デジタル線量吸入器市場で展開される戦略

第5章 世界のデジタル線量吸入器市場：製品別

  • 世界の定量吸入器（MDI）市場：地域別
  • 世界のドライパウダー吸入器（DPI）市場：地域別

第6章 世界のデジタル線量吸入器市場：タイプ別

  • 世界のブランド医薬品市場：地域別
  • 世界のジェネリック医薬品市場：地域別

第7章 世界のデジタル線量吸入器市場：適応症別

  • 世界のCOPD市場：地域別
  • 世界の喘息市場：地域別
  • 世界のその他の市場：地域別

第8章 世界のデジタル線量吸入器市場：地域別

  • 北米
    • 北米の市場：国別
      • 米国
      • カナダ
      • メキシコ
      • その他北米地域
  • 欧州
    • 欧州の市場：国別
      • ドイツ
      • 英国
      • フランス
      • ロシア
      • スペイン
      • イタリア
      • その他欧州地域
  • アジア太平洋
    • アジア太平洋の市場：国別
      • 中国
      • 日本
      • インド
      • 韓国
      • シンガポール
      • マレーシア
      • その他アジア太平洋地域
  • ラテンアメリカ・中東・アフリカ
    • ラテンアメリカ・中東・アフリカの市場：国別
      • ブラジル
      • アルゼンチン
      • アラブ首長国連邦
      • サウジアラビア
      • 南アフリカ
      • ナイジェリア
      • その他ラテンアメリカ・中東・アフリカ地域

第9章 企業プロファイル

  • Sensirion AG
  • Teva Pharmaceutical Industries Ltd
  • OPKO Health, Inc
  • Propeller Health（ResMed, Inc）
  • Novartis AG
  • AstraZeneca PLC
  • Glenmark Pharmaceuticals Limited
  • Beximco Pharmaceuticals Ltd
  • GlaxoSmithKline PLC（GSK）
  • Mundipharma Deutschland GmbH & Co KG

第10章 デジタル線量吸入器市場での勝利は必須

図表

LIST OF TABLES

  • TABLE 1 Global Digital Dose Inhaler Market, 2019 - 2022, USD Million
  • TABLE 2 Global Digital Dose Inhaler Market, 2023 - 2030, USD Million
  • TABLE 3 Global Digital Dose Inhaler Market by Product, 2019 - 2022, USD Million
  • TABLE 4 Global Digital Dose Inhaler Market by Product, 2023 - 2030, USD Million
  • TABLE 5 Global Metered Dose Inhaler (MDI) Market by Region, 2019 - 2022, USD Million
  • TABLE 6 Global Metered Dose Inhaler (MDI) Market by Region, 2023 - 2030, USD Million
  • TABLE 7 Global Dry Powder Inhaler (DPI) Market by Region, 2019 - 2022, USD Million
  • TABLE 8 Global Dry Powder Inhaler (DPI) Market by Region, 2023 - 2030, USD Million
  • TABLE 9 Global Digital Dose Inhaler Market by Type, 2019 - 2022, USD Million
  • TABLE 10 Global Digital Dose Inhaler Market by Type, 2023 - 2030, USD Million
  • TABLE 11 Global Branded Medication Market by Region, 2019 - 2022, USD Million
  • TABLE 12 Global Branded Medication Market by Region, 2023 - 2030, USD Million
  • TABLE 13 Global Generic Medication Market by Region, 2019 - 2022, USD Million
  • TABLE 14 Global Generic Medication Market by Region, 2023 - 2030, USD Million
  • TABLE 15 Global Digital Dose Inhaler Market by Indication, 2019 - 2022, USD Million
  • TABLE 16 Global Digital Dose Inhaler Market by Indication, 2023 - 2030, USD Million
  • TABLE 17 Global COPD Market by Region, 2019 - 2022, USD Million
  • TABLE 18 Global COPD Market by Region, 2023 - 2030, USD Million
  • TABLE 19 Global Asthma Market by Region, 2019 - 2022, USD Million
  • TABLE 20 Global Asthma Market by Region, 2023 - 2030, USD Million
  • TABLE 21 Global Others Market by Region, 2019 - 2022, USD Million
  • TABLE 22 Global Others Market by Region, 2023 - 2030, USD Million
  • TABLE 23 Global Digital Dose Inhaler Market by Region, 2019 - 2022, USD Million
  • TABLE 24 Global Digital Dose Inhaler Market by Region, 2023 - 2030, USD Million
  • TABLE 25 North America Digital Dose Inhaler Market, 2019 - 2022, USD Million
  • TABLE 26 North America Digital Dose Inhaler Market, 2023 - 2030, USD Million
  • TABLE 27 North America Digital Dose Inhaler Market by Product, 2019 - 2022, USD Million
  • TABLE 28 North America Digital Dose Inhaler Market by Product, 2023 - 2030, USD Million
  • TABLE 29 North America Metered Dose Inhaler (MDI) Market by Country, 2019 - 2022, USD Million
  • TABLE 30 North America Metered Dose Inhaler (MDI) Market by Country, 2023 - 2030, USD Million
  • TABLE 31 North America Dry Powder Inhaler (DPI) Market by Country, 2019 - 2022, USD Million
  • TABLE 32 North America Dry Powder Inhaler (DPI) Market by Country, 2023 - 2030, USD Million
  • TABLE 33 North America Digital Dose Inhaler Market by Type, 2019 - 2022, USD Million
  • TABLE 34 North America Digital Dose Inhaler Market by Type, 2023 - 2030, USD Million
  • TABLE 35 North America Branded Medication Market by Country, 2019 - 2022, USD Million
  • TABLE 36 North America Branded Medication Market by Country, 2023 - 2030, USD Million
  • TABLE 37 North America Generic Medication Market by Country, 2019 - 2022, USD Million
  • TABLE 38 North America Generic Medication Market by Country, 2023 - 2030, USD Million
  • TABLE 39 North America Digital Dose Inhaler Market by Indication, 2019 - 2022, USD Million
  • TABLE 40 North America Digital Dose Inhaler Market by Indication, 2023 - 2030, USD Million
  • TABLE 41 North America COPD Market by Country, 2019 - 2022, USD Million
  • TABLE 42 North America COPD Market by Country, 2023 - 2030, USD Million
  • TABLE 43 North America Asthma Market by Country, 2019 - 2022, USD Million
  • TABLE 44 North America Asthma Market by Country, 2023 - 2030, USD Million
  • TABLE 45 North America Others Market by Country, 2019 - 2022, USD Million
  • TABLE 46 North America Others Market by Country, 2023 - 2030, USD Million
  • TABLE 47 North America Digital Dose Inhaler Market by Country, 2019 - 2022, USD Million
  • TABLE 48 North America Digital Dose Inhaler Market by Country, 2023 - 2030, USD Million
  • TABLE 49 US Digital Dose Inhaler Market, 2019 - 2022, USD Million
  • TABLE 50 US Digital Dose Inhaler Market, 2023 - 2030, USD Million
  • TABLE 51 US Digital Dose Inhaler Market by Product, 2019 - 2022, USD Million
  • TABLE 52 US Digital Dose Inhaler Market by Product, 2023 - 2030, USD Million
  • TABLE 53 US Digital Dose Inhaler Market by Type, 2019 - 2022, USD Million
  • TABLE 54 US Digital Dose Inhaler Market by Type, 2023 - 2030, USD Million
  • TABLE 55 US Digital Dose Inhaler Market by Indication, 2019 - 2022, USD Million
  • TABLE 56 US Digital Dose Inhaler Market by Indication, 2023 - 2030, USD Million
  • TABLE 57 Canada Digital Dose Inhaler Market, 2019 - 2022, USD Million
  • TABLE 58 Canada Digital Dose Inhaler Market, 2023 - 2030, USD Million
  • TABLE 59 Canada Digital Dose Inhaler Market by Product, 2019 - 2022, USD Million
  • TABLE 60 Canada Digital Dose Inhaler Market by Product, 2023 - 2030, USD Million
  • TABLE 61 Canada Digital Dose Inhaler Market by Type, 2019 - 2022, USD Million
  • TABLE 62 Canada Digital Dose Inhaler Market by Type, 2023 - 2030, USD Million
  • TABLE 63 Canada Digital Dose Inhaler Market by Indication, 2019 - 2022, USD Million
  • TABLE 64 Canada Digital Dose Inhaler Market by Indication, 2023 - 2030, USD Million
  • TABLE 65 Mexico Digital Dose Inhaler Market, 2019 - 2022, USD Million
  • TABLE 66 Mexico Digital Dose Inhaler Market, 2023 - 2030, USD Million
  • TABLE 67 Mexico Digital Dose Inhaler Market by Product, 2019 - 2022, USD Million
  • TABLE 68 Mexico Digital Dose Inhaler Market by Product, 2023 - 2030, USD Million
  • TABLE 69 Mexico Digital Dose Inhaler Market by Type, 2019 - 2022, USD Million
  • TABLE 70 Mexico Digital Dose Inhaler Market by Type, 2023 - 2030, USD Million
  • TABLE 71 Mexico Digital Dose Inhaler Market by Indication, 2019 - 2022, USD Million
  • TABLE 72 Mexico Digital Dose Inhaler Market by Indication, 2023 - 2030, USD Million
  • TABLE 73 Rest of North America Digital Dose Inhaler Market, 2019 - 2022, USD Million
  • TABLE 74 Rest of North America Digital Dose Inhaler Market, 2023 - 2030, USD Million
  • TABLE 75 Rest of North America Digital Dose Inhaler Market by Product, 2019 - 2022, USD Million
  • TABLE 76 Rest of North America Digital Dose Inhaler Market by Product, 2023 - 2030, USD Million
  • TABLE 77 Rest of North America Digital Dose Inhaler Market by Type, 2019 - 2022, USD Million
  • TABLE 78 Rest of North America Digital Dose Inhaler Market by Type, 2023 - 2030, USD Million
  • TABLE 79 Rest of North America Digital Dose Inhaler Market by Indication, 2019 - 2022, USD Million
  • TABLE 80 Rest of North America Digital Dose Inhaler Market by Indication, 2023 - 2030, USD Million
  • TABLE 81 Europe Digital Dose Inhaler Market, 2019 - 2022, USD Million
  • TABLE 82 Europe Digital Dose Inhaler Market, 2023 - 2030, USD Million
  • TABLE 83 Europe Digital Dose Inhaler Market by Product, 2019 - 2022, USD Million
  • TABLE 84 Europe Digital Dose Inhaler Market by Product, 2023 - 2030, USD Million
  • TABLE 85 Europe Metered Dose Inhaler (MDI) Market by Country, 2019 - 2022, USD Million
  • TABLE 86 Europe Metered Dose Inhaler (MDI) Market by Country, 2023 - 2030, USD Million
  • TABLE 87 Europe Dry Powder Inhaler (DPI) Market by Country, 2019 - 2022, USD Million
  • TABLE 88 Europe Dry Powder Inhaler (DPI) Market by Country, 2023 - 2030, USD Million
  • TABLE 89 Europe Digital Dose Inhaler Market by Type, 2019 - 2022, USD Million
  • TABLE 90 Europe Digital Dose Inhaler Market by Type, 2023 - 2030, USD Million
  • TABLE 91 Europe Branded Medication Market by Country, 2019 - 2022, USD Million
  • TABLE 92 Europe Branded Medication Market by Country, 2023 - 2030, USD Million
  • TABLE 93 Europe Generic Medication Market by Country, 2019 - 2022, USD Million
  • TABLE 94 Europe Generic Medication Market by Country, 2023 - 2030, USD Million
  • TABLE 95 Europe Digital Dose Inhaler Market by Indication, 2019 - 2022, USD Million
  • TABLE 96 Europe Digital Dose Inhaler Market by Indication, 2023 - 2030, USD Million
  • TABLE 97 Europe COPD Market by Country, 2019 - 2022, USD Million
  • TABLE 98 Europe COPD Market by Country, 2023 - 2030, USD Million
  • TABLE 99 Europe Asthma Market by Country, 2019 - 2022, USD Million
  • TABLE 100 Europe Asthma Market by Country, 2023 - 2030, USD Million
  • TABLE 101 Europe Others Market by Country, 2019 - 2022, USD Million
  • TABLE 102 Europe Others Market by Country, 2023 - 2030, USD Million
  • TABLE 103 Europe Digital Dose Inhaler Market by Country, 2019 - 2022, USD Million
  • TABLE 104 Europe Digital Dose Inhaler Market by Country, 2023 - 2030, USD Million
  • TABLE 105 Germany Digital Dose Inhaler Market, 2019 - 2022, USD Million
  • TABLE 106 Germany Digital Dose Inhaler Market, 2023 - 2030, USD Million
  • TABLE 107 Germany Digital Dose Inhaler Market by Product, 2019 - 2022, USD Million
  • TABLE 108 Germany Digital Dose Inhaler Market by Product, 2023 - 2030, USD Million
  • TABLE 109 Germany Digital Dose Inhaler Market by Type, 2019 - 2022, USD Million
  • TABLE 110 Germany Digital Dose Inhaler Market by Type, 2023 - 2030, USD Million
  • TABLE 111 Germany Digital Dose Inhaler Market by Indication, 2019 - 2022, USD Million
  • TABLE 112 Germany Digital Dose Inhaler Market by Indication, 2023 - 2030, USD Million
  • TABLE 113 UK Digital Dose Inhaler Market, 2019 - 2022, USD Million
  • TABLE 114 UK Digital Dose Inhaler Market, 2023 - 2030, USD Million
  • TABLE 115 UK Digital Dose Inhaler Market by Product, 2019 - 2022, USD Million
  • TABLE 116 UK Digital Dose Inhaler Market by Product, 2023 - 2030, USD Million
  • TABLE 117 UK Digital Dose Inhaler Market by Type, 2019 - 2022, USD Million
  • TABLE 118 UK Digital Dose Inhaler Market by Type, 2023 - 2030, USD Million
  • TABLE 119 UK Digital Dose Inhaler Market by Indication, 2019 - 2022, USD Million
  • TABLE 120 UK Digital Dose Inhaler Market by Indication, 2023 - 2030, USD Million
  • TABLE 121 France Digital Dose Inhaler Market, 2019 - 2022, USD Million
  • TABLE 122 France Digital Dose Inhaler Market, 2023 - 2030, USD Million
  • TABLE 123 France Digital Dose Inhaler Market by Product, 2019 - 2022, USD Million
  • TABLE 124 France Digital Dose Inhaler Market by Product, 2023 - 2030, USD Million
  • TABLE 125 France Digital Dose Inhaler Market by Type, 2019 - 2022, USD Million
  • TABLE 126 France Digital Dose Inhaler Market by Type, 2023 - 2030, USD Million
  • TABLE 127 France Digital Dose Inhaler Market by Indication, 2019 - 2022, USD Million
  • TABLE 128 France Digital Dose Inhaler Market by Indication, 2023 - 2030, USD Million
  • TABLE 129 Russia Digital Dose Inhaler Market, 2019 - 2022, USD Million
  • TABLE 130 Russia Digital Dose Inhaler Market, 2023 - 2030, USD Million
  • TABLE 131 Russia Digital Dose Inhaler Market by Product, 2019 - 2022, USD Million
  • TABLE 132 Russia Digital Dose Inhaler Market by Product, 2023 - 2030, USD Million
  • TABLE 133 Russia Digital Dose Inhaler Market by Type, 2019 - 2022, USD Million
  • TABLE 134 Russia Digital Dose Inhaler Market by Type, 2023 - 2030, USD Million
  • TABLE 135 Russia Digital Dose Inhaler Market by Indication, 2019 - 2022, USD Million
  • TABLE 136 Russia Digital Dose Inhaler Market by Indication, 2023 - 2030, USD Million
  • TABLE 137 Spain Digital Dose Inhaler Market, 2019 - 2022, USD Million
  • TABLE 138 Spain Digital Dose Inhaler Market, 2023 - 2030, USD Million
  • TABLE 139 Spain Digital Dose Inhaler Market by Product, 2019 - 2022, USD Million
  • TABLE 140 Spain Digital Dose Inhaler Market by Product, 2023 - 2030, USD Million
  • TABLE 141 Spain Digital Dose Inhaler Market by Type, 2019 - 2022, USD Million
  • TABLE 142 Spain Digital Dose Inhaler Market by Type, 2023 - 2030, USD Million
  • TABLE 143 Spain Digital Dose Inhaler Market by Indication, 2019 - 2022, USD Million
  • TABLE 144 Spain Digital Dose Inhaler Market by Indication, 2023 - 2030, USD Million
  • TABLE 145 Italy Digital Dose Inhaler Market, 2019 - 2022, USD Million
  • TABLE 146 Italy Digital Dose Inhaler Market, 2023 - 2030, USD Million
  • TABLE 147 Italy Digital Dose Inhaler Market by Product, 2019 - 2022, USD Million
  • TABLE 148 Italy Digital Dose Inhaler Market by Product, 2023 - 2030, USD Million
  • TABLE 149 Italy Digital Dose Inhaler Market by Type, 2019 - 2022, USD Million
  • TABLE 150 Italy Digital Dose Inhaler Market by Type, 2023 - 2030, USD Million
  • TABLE 151 Italy Digital Dose Inhaler Market by Indication, 2019 - 2022, USD Million
  • TABLE 152 Italy Digital Dose Inhaler Market by Indication, 2023 - 2030, USD Million
  • TABLE 153 Rest of Europe Digital Dose Inhaler Market, 2019 - 2022, USD Million
  • TABLE 154 Rest of Europe Digital Dose Inhaler Market, 2023 - 2030, USD Million
  • TABLE 155 Rest of Europe Digital Dose Inhaler Market by Product, 2019 - 2022, USD Million
  • TABLE 156 Rest of Europe Digital Dose Inhaler Market by Product, 2023 - 2030, USD Million
  • TABLE 157 Rest of Europe Digital Dose Inhaler Market by Type, 2019 - 2022, USD Million
  • TABLE 158 Rest of Europe Digital Dose Inhaler Market by Type, 2023 - 2030, USD Million
  • TABLE 159 Rest of Europe Digital Dose Inhaler Market by Indication, 2019 - 2022, USD Million
  • TABLE 160 Rest of Europe Digital Dose Inhaler Market by Indication, 2023 - 2030, USD Million
  • TABLE 161 Asia Pacific Digital Dose Inhaler Market, 2019 - 2022, USD Million
  • TABLE 162 Asia Pacific Digital Dose Inhaler Market, 2023 - 2030, USD Million
  • TABLE 163 Asia Pacific Digital Dose Inhaler Market by Product, 2019 - 2022, USD Million
  • TABLE 164 Asia Pacific Digital Dose Inhaler Market by Product, 2023 - 2030, USD Million
  • TABLE 165 Asia Pacific Metered Dose Inhaler (MDI) Market by Country, 2019 - 2022, USD Million
  • TABLE 166 Asia Pacific Metered Dose Inhaler (MDI) Market by Country, 2023 - 2030, USD Million
  • TABLE 167 Asia Pacific Dry Powder Inhaler (DPI) Market by Country, 2019 - 2022, USD Million
  • TABLE 168 Asia Pacific Dry Powder Inhaler (DPI) Market by Country, 2023 - 2030, USD Million
  • TABLE 169 Asia Pacific Digital Dose Inhaler Market by Type, 2019 - 2022, USD Million
  • TABLE 170 Asia Pacific Digital Dose Inhaler Market by Type, 2023 - 2030, USD Million
  • TABLE 171 Asia Pacific Branded Medication Market by Country, 2019 - 2022, USD Million
  • TABLE 172 Asia Pacific Branded Medication Market by Country, 2023 - 2030, USD Million
  • TABLE 173 Asia Pacific Generic Medication Market by Country, 2019 - 2022, USD Million
  • TABLE 174 Asia Pacific Generic Medication Market by Country, 2023 - 2030, USD Million
  • TABLE 175 Asia Pacific Digital Dose Inhaler Market by Indication, 2019 - 2022, USD Million
  • TABLE 176 Asia Pacific Digital Dose Inhaler Market by Indication, 2023 - 2030, USD Million
  • TABLE 177 Asia Pacific COPD Market by Country, 2019 - 2022, USD Million
  • TABLE 178 Asia Pacific COPD Market by Country, 2023 - 2030, USD Million
  • TABLE 179 Asia Pacific Asthma Market by Country, 2019 - 2022, USD Million
  • TABLE 180 Asia Pacific Asthma Market by Country, 2023 - 2030, USD Million
  • TABLE 181 Asia Pacific Others Market by Country, 2019 - 2022, USD Million
  • TABLE 182 Asia Pacific Others Market by Country, 2023 - 2030, USD Million
  • TABLE 183 Asia Pacific Digital Dose Inhaler Market by Country, 2019 - 2022, USD Million
  • TABLE 184 Asia Pacific Digital Dose Inhaler Market by Country, 2023 - 2030, USD Million
  • TABLE 185 China Digital Dose Inhaler Market, 2019 - 2022, USD Million
  • TABLE 186 China Digital Dose Inhaler Market, 2023 - 2030, USD Million
  • TABLE 187 China Digital Dose Inhaler Market by Product, 2019 - 2022, USD Million
  • TABLE 188 China Digital Dose Inhaler Market by Product, 2023 - 2030, USD Million
  • TABLE 189 China Digital Dose Inhaler Market by Type, 2019 - 2022, USD Million
  • TABLE 190 China Digital Dose Inhaler Market by Type, 2023 - 2030, USD Million
  • TABLE 191 China Digital Dose Inhaler Market by Indication, 2019 - 2022, USD Million
  • TABLE 192 China Digital Dose Inhaler Market by Indication, 2023 - 2030, USD Million
  • TABLE 193 Japan Digital Dose Inhaler Market, 2019 - 2022, USD Million
  • TABLE 194 Japan Digital Dose Inhaler Market, 2023 - 2030, USD Million
  • TABLE 195 Japan Digital Dose Inhaler Market by Product, 2019 - 2022, USD Million
  • TABLE 196 Japan Digital Dose Inhaler Market by Product, 2023 - 2030, USD Million
  • TABLE 197 Japan Digital Dose Inhaler Market by Type, 2019 - 2022, USD Million
  • TABLE 198 Japan Digital Dose Inhaler Market by Type, 2023 - 2030, USD Million
  • TABLE 199 Japan Digital Dose Inhaler Market by Indication, 2019 - 2022, USD Million
  • TABLE 200 Japan Digital Dose Inhaler Market by Indication, 2023 - 2030, USD Million
  • TABLE 201 India Digital Dose Inhaler Market, 2019 - 2022, USD Million
  • TABLE 202 India Digital Dose Inhaler Market, 2023 - 2030, USD Million
  • TABLE 203 India Digital Dose Inhaler Market by Product, 2019 - 2022, USD Million
  • TABLE 204 India Digital Dose Inhaler Market by Product, 2023 - 2030, USD Million
  • TABLE 205 India Digital Dose Inhaler Market by Type, 2019 - 2022, USD Million
  • TABLE 206 India Digital Dose Inhaler Market by Type, 2023 - 2030, USD Million
  • TABLE 207 India Digital Dose Inhaler Market by Indication, 2019 - 2022, USD Million
  • TABLE 208 India Digital Dose Inhaler Market by Indication, 2023 - 2030, USD Million
  • TABLE 209 South Korea Digital Dose Inhaler Market, 2019 - 2022, USD Million
  • TABLE 210 South Korea Digital Dose Inhaler Market, 2023 - 2030, USD Million
  • TABLE 211 South Korea Digital Dose Inhaler Market by Product, 2019 - 2022, USD Million
  • TABLE 212 South Korea Digital Dose Inhaler Market by Product, 2023 - 2030, USD Million
  • TABLE 213 South Korea Digital Dose Inhaler Market by Type, 2019 - 2022, USD Million
  • TABLE 214 South Korea Digital Dose Inhaler Market by Type, 2023 - 2030, USD Million
  • TABLE 215 South Korea Digital Dose Inhaler Market by Indication, 2019 - 2022, USD Million
  • TABLE 216 South Korea Digital Dose Inhaler Market by Indication, 2023 - 2030, USD Million
  • TABLE 217 Singapore Digital Dose Inhaler Market, 2019 - 2022, USD Million
  • TABLE 218 Singapore Digital Dose Inhaler Market, 2023 - 2030, USD Million
  • TABLE 219 Singapore Digital Dose Inhaler Market by Product, 2019 - 2022, USD Million
  • TABLE 220 Singapore Digital Dose Inhaler Market by Product, 2023 - 2030, USD Million
  • TABLE 221 Singapore Digital Dose Inhaler Market by Type, 2019 - 2022, USD Million
  • TABLE 222 Singapore Digital Dose Inhaler Market by Type, 2023 - 2030, USD Million
  • TABLE 223 Singapore Digital Dose Inhaler Market by Indication, 2019 - 2022, USD Million
  • TABLE 224 Singapore Digital Dose Inhaler Market by Indication, 2023 - 2030, USD Million
  • TABLE 225 Malaysia Digital Dose Inhaler Market, 2019 - 2022, USD Million
  • TABLE 226 Malaysia Digital Dose Inhaler Market, 2023 - 2030, USD Million
  • TABLE 227 Malaysia Digital Dose Inhaler Market by Product, 2019 - 2022, USD Million
  • TABLE 228 Malaysia Digital Dose Inhaler Market by Product, 2023 - 2030, USD Million
  • TABLE 229 Malaysia Digital Dose Inhaler Market by Type, 2019 - 2022, USD Million
  • TABLE 230 Malaysia Digital Dose Inhaler Market by Type, 2023 - 2030, USD Million
  • TABLE 231 Malaysia Digital Dose Inhaler Market by Indication, 2019 - 2022, USD Million
  • TABLE 232 Malaysia Digital Dose Inhaler Market by Indication, 2023 - 2030, USD Million
  • TABLE 233 Rest of Asia Pacific Digital Dose Inhaler Market, 2019 - 2022, USD Million
  • TABLE 234 Rest of Asia Pacific Digital Dose Inhaler Market, 2023 - 2030, USD Million
  • TABLE 235 Rest of Asia Pacific Digital Dose Inhaler Market by Product, 2019 - 2022, USD Million
  • TABLE 236 Rest of Asia Pacific Digital Dose Inhaler Market by Product, 2023 - 2030, USD Million
  • TABLE 237 Rest of Asia Pacific Digital Dose Inhaler Market by Type, 2019 - 2022, USD Million
  • TABLE 238 Rest of Asia Pacific Digital Dose Inhaler Market by Type, 2023 - 2030, USD Million
  • TABLE 239 Rest of Asia Pacific Digital Dose Inhaler Market by Indication, 2019 - 2022, USD Million
  • TABLE 240 Rest of Asia Pacific Digital Dose Inhaler Market by Indication, 2023 - 2030, USD Million
  • TABLE 241 LAMEA Digital Dose Inhaler Market, 2019 - 2022, USD Million
  • TABLE 242 LAMEA Digital Dose Inhaler Market, 2023 - 2030, USD Million
  • TABLE 243 LAMEA Digital Dose Inhaler Market by Product, 2019 - 2022, USD Million
  • TABLE 244 LAMEA Digital Dose Inhaler Market by Product, 2023 - 2030, USD Million
  • TABLE 245 LAMEA Metered Dose Inhaler (MDI) Market by Country, 2019 - 2022, USD Million
  • TABLE 246 LAMEA Metered Dose Inhaler (MDI) Market by Country, 2023 - 2030, USD Million
  • TABLE 247 LAMEA Dry Powder Inhaler (DPI) Market by Country, 2019 - 2022, USD Million
  • TABLE 248 LAMEA Dry Powder Inhaler (DPI) Market by Country, 2023 - 2030, USD Million
  • TABLE 249 LAMEA Digital Dose Inhaler Market by Type, 2019 - 2022, USD Million
  • TABLE 250 LAMEA Digital Dose Inhaler Market by Type, 2023 - 2030, USD Million
  • TABLE 251 LAMEA Branded Medication Market by Country, 2019 - 2022, USD Million
  • TABLE 252 LAMEA Branded Medication Market by Country, 2023 - 2030, USD Million
  • TABLE 253 LAMEA Generic Medication Market by Country, 2019 - 2022, USD Million
  • TABLE 254 LAMEA Generic Medication Market by Country, 2023 - 2030, USD Million
  • TABLE 255 LAMEA Digital Dose Inhaler Market by Indication, 2019 - 2022, USD Million
  • TABLE 256 LAMEA Digital Dose Inhaler Market by Indication, 2023 - 2030, USD Million
  • TABLE 257 LAMEA COPD Market by Country, 2019 - 2022, USD Million
  • TABLE 258 LAMEA COPD Market by Country, 2023 - 2030, USD Million
  • TABLE 259 LAMEA Asthma Market by Country, 2019 - 2022, USD Million
  • TABLE 260 LAMEA Asthma Market by Country, 2023 - 2030, USD Million
  • TABLE 261 LAMEA Others Market by Country, 2019 - 2022, USD Million
  • TABLE 262 LAMEA Others Market by Country, 2023 - 2030, USD Million
  • TABLE 263 LAMEA Digital Dose Inhaler Market by Country, 2019 - 2022, USD Million
  • TABLE 264 LAMEA Digital Dose Inhaler Market by Country, 2023 - 2030, USD Million
  • TABLE 265 Brazil Digital Dose Inhaler Market, 2019 - 2022, USD Million
  • TABLE 266 Brazil Digital Dose Inhaler Market, 2023 - 2030, USD Million
  • TABLE 267 Brazil Digital Dose Inhaler Market by Product, 2019 - 2022, USD Million
  • TABLE 268 Brazil Digital Dose Inhaler Market by Product, 2023 - 2030, USD Million
  • TABLE 269 Brazil Digital Dose Inhaler Market by Type, 2019 - 2022, USD Million
  • TABLE 270 Brazil Digital Dose Inhaler Market by Type, 2023 - 2030, USD Million
  • TABLE 271 Brazil Digital Dose Inhaler Market by Indication, 2019 - 2022, USD Million
  • TABLE 272 Brazil Digital Dose Inhaler Market by Indication, 2023 - 2030, USD Million
  • TABLE 273 Argentina Digital Dose Inhaler Market, 2019 - 2022, USD Million
  • TABLE 274 Argentina Digital Dose Inhaler Market, 2023 - 2030, USD Million
  • TABLE 275 Argentina Digital Dose Inhaler Market by Product, 2019 - 2022, USD Million
  • TABLE 276 Argentina Digital Dose Inhaler Market by Product, 2023 - 2030, USD Million
  • TABLE 277 Argentina Digital Dose Inhaler Market by Type, 2019 - 2022, USD Million
  • TABLE 278 Argentina Digital Dose Inhaler Market by Type, 2023 - 2030, USD Million
  • TABLE 279 Argentina Digital Dose Inhaler Market by Indication, 2019 - 2022, USD Million
  • TABLE 280 Argentina Digital Dose Inhaler Market by Indication, 2023 - 2030, USD Million
  • TABLE 281 UAE Digital Dose Inhaler Market, 2019 - 2022, USD Million
  • TABLE 282 UAE Digital Dose Inhaler Market, 2023 - 2030, USD Million
  • TABLE 283 UAE Digital Dose Inhaler Market by Product, 2019 - 2022, USD Million
  • TABLE 284 UAE Digital Dose Inhaler Market by Product, 2023 - 2030, USD Million
  • TABLE 285 UAE Digital Dose Inhaler Market by Type, 2019 - 2022, USD Million
  • TABLE 286 UAE Digital Dose Inhaler Market by Type, 2023 - 2030, USD Million
  • TABLE 287 UAE Digital Dose Inhaler Market by Indication, 2019 - 2022, USD Million
  • TABLE 288 UAE Digital Dose Inhaler Market by Indication, 2023 - 2030, USD Million
  • TABLE 289 Saudi Arabia Digital Dose Inhaler Market, 2019 - 2022, USD Million
  • TABLE 290 Saudi Arabia Digital Dose Inhaler Market, 2023 - 2030, USD Million
  • TABLE 291 Saudi Arabia Digital Dose Inhaler Market by Product, 2019 - 2022, USD Million
  • TABLE 292 Saudi Arabia Digital Dose Inhaler Market by Product, 2023 - 2030, USD Million
  • TABLE 293 Saudi Arabia Digital Dose Inhaler Market by Type, 2019 - 2022, USD Million
  • TABLE 294 Saudi Arabia Digital Dose Inhaler Market by Type, 2023 - 2030, USD Million
  • TABLE 295 Saudi Arabia Digital Dose Inhaler Market by Indication, 2019 - 2022, USD Million
  • TABLE 296 Saudi Arabia Digital Dose Inhaler Market by Indication, 2023 - 2030, USD Million
  • TABLE 297 South Africa Digital Dose Inhaler Market, 2019 - 2022, USD Million
  • TABLE 298 South Africa Digital Dose Inhaler Market, 2023 - 2030, USD Million
  • TABLE 299 South Africa Digital Dose Inhaler Market by Product, 2019 - 2022, USD Million
  • TABLE 300 South Africa Digital Dose Inhaler Market by Product, 2023 - 2030, USD Million
  • TABLE 301 South Africa Digital Dose Inhaler Market by Type, 2019 - 2022, USD Million
  • TABLE 302 South Africa Digital Dose Inhaler Market by Type, 2023 - 2030, USD Million
  • TABLE 303 South Africa Digital Dose Inhaler Market by Indication, 2019 - 2022, USD Million
  • TABLE 304 South Africa Digital Dose Inhaler Market by Indication, 2023 - 2030, USD Million
  • TABLE 305 Nigeria Digital Dose Inhaler Market, 2019 - 2022, USD Million
  • TABLE 306 Nigeria Digital Dose Inhaler Market, 2023 - 2030, USD Million
  • TABLE 307 Nigeria Digital Dose Inhaler Market by Product, 2019 - 2022, USD Million
  • TABLE 308 Nigeria Digital Dose Inhaler Market by Product, 2023 - 2030, USD Million
  • TABLE 309 Nigeria Digital Dose Inhaler Market by Type, 2019 - 2022, USD Million
  • TABLE 310 Nigeria Digital Dose Inhaler Market by Type, 2023 - 2030, USD Million
  • TABLE 311 Nigeria Digital Dose Inhaler Market by Indication, 2019 - 2022, USD Million
  • TABLE 312 Nigeria Digital Dose Inhaler Market by Indication, 2023 - 2030, USD Million
  • TABLE 313 Rest of LAMEA Digital Dose Inhaler Market, 2019 - 2022, USD Million
  • TABLE 314 Rest of LAMEA Digital Dose Inhaler Market, 2023 - 2030, USD Million
  • TABLE 315 Rest of LAMEA Digital Dose Inhaler Market by Product, 2019 - 2022, USD Million
  • TABLE 316 Rest of LAMEA Digital Dose Inhaler Market by Product, 2023 - 2030, USD Million
  • TABLE 317 Rest of LAMEA Digital Dose Inhaler Market by Type, 2019 - 2022, USD Million
  • TABLE 318 Rest of LAMEA Digital Dose Inhaler Market by Type, 2023 - 2030, USD Million
  • TABLE 319 Rest of LAMEA Digital Dose Inhaler Market by Indication, 2019 - 2022, USD Million
  • TABLE 320 Rest of LAMEA Digital Dose Inhaler Market by Indication, 2023 - 2030, USD Million
  • TABLE 321 Key Information - Sensirion AG
  • TABLE 322 Key Information - Teva Pharmaceuticals Industries Ltd.
  • TABLE 323 Key Information - OPKO Health, Inc.
  • TABLE 324 Key Information - Propeller Health
  • TABLE 325 Key Information - Novartis AG
  • TABLE 326 KEY INFORMATION - AstraZeneca PLC
  • TABLE 327 Key Information - Glenmark Pharmaceuticals Limited
  • TABLE 328 Key Information - Beximco Pharmaceuticals Ltd.
  • TABLE 329 Key Information - GlaxoSmithKline PLC
  • TABLE 330 Key Information - Mundipharma Deutschland GmbH & Co. KG

List of Figures

  • FIG 1 Methodology for the research
  • FIG 2 Global Digital Dose Inhaler Market, 2019 - 2030, USD Million
  • FIG 3 Key Impacting Factors digital dose inhaler market
  • FIG 4 Porter's Five Force Analysis: Digital Dose Inhaler Market
  • FIG 5 Global Digital Dose Inhaler Market share by Product, 2022
  • FIG 6 Global Digital Dose Inhaler Market share by Product, 2030
  • FIG 7 Global Digital Dose Inhaler Market by Product, 2019 - 2030, USD Million
  • FIG 8 Global Digital Dose Inhaler Market share by Type, 2022
  • FIG 9 Global Digital Dose Inhaler Market share by Type, 2030
  • FIG 10 Global Digital Dose Inhaler Market by Type, 2019 - 2030, USD Million
  • FIG 11 Global Digital Dose Inhaler Market share by Indication, 2022
  • FIG 12 Global Digital Dose Inhaler Market share by Indication, 2030
  • FIG 13 Global Digital Dose Inhaler Market by Indication, 2019 - 2030, USD Million
  • FIG 14 Global Digital Dose Inhaler Market share by Region, 2022
  • FIG 15 Global Digital Dose Inhaler Market share by Region, 2030
  • FIG 16 Global Digital Dose Inhaler Market by Region, 2019 - 2030, USD Million
  • FIG 17 SWOT Analysis: SENSIRION AG
  • FIG 18 Recent strategies and developments: Teva Pharmaceuticals Industries Ltd.
  • FIG 19 SWOT Analysis: Teva Pharmaceuticals Industries Ltd.
  • FIG 20 SWOT Analysis: OPKO Health, Inc.
  • FIG 21 SWOT Analysis: Propeller Health
  • FIG 22 SWOT Analysis: Novartis AG
  • FIG 23 SWOT Analysis: AstraZeneca PLC
  • FIG 24 SWOT Analysis: Glenmark Pharmaceuticals Ltd.
  • FIG 25 SWOT Analysis: Beximco Pharmaceuticals Ltd.
  • FIG 26 SWOT Analysis: GlaxoSmithKline PLC
  • FIG 27 SWOT Analysis: Mundipharma Deutschland GmbH & Co. KG
目次

The Global Digital Dose Inhaler Market size is expected to reach $49 billion by 2030, rising at a market growth of 19.6% CAGR during the forecast period.

Cigarette smoking and long-term exposure to other respiratory contaminants are typically the cause of various diseases, including asthma. The asthma segment will capture more than 30% share of the market by 2030. The World Health Organization (WHO) estimates that annually, tobacco kills more than eight million people. 7 million deaths are due to direct tobacco use, while approximately 1.2 million are due to latent or secondhand smoking. Cigarette smoking is one of the most prevalent forms of tobacco use worldwide. Over 80% of the 1.3 billion tobacco consumers reside in low- and middle-income countries, where mortality and illness due to tobacco use are prevalent. Some of the factors impacting the market are globally increasing air pollution, developing technological advances and concerns related to patient data security.

Automobiles, forest fires, household combustion, and industrial facilities are widely recognized sources of air pollution. Particulate matter, ozone, carbon monoxide, sulfur dioxide, and nitrogen are the pollutants of most threat to public health. Both indoor and external air pollution contribute significantly to mortality and morbidity by causing respiratory and other diseases. According to the World Health Organization, nearly all the world's population consumes air with elevated levels of pollutants exceeding WHO guidelines. Low- and middle-income countries are the most vulnerable to these threats. Additionally, the increasing adoption of AI and IoT has been identified as one of the most significant market trends. AI technology analyzes intricate medical data using algorithms and software, reducing the need for direct human input. This will aid in decreasing the likelihood of human error, reducing treatment costs, and enhancing healthcare outcomes. Therefore, Long-term exposure to ambient air contaminants is associated with an increase in the incidence of respiratory diseases and the increasing incorporation of AI and the adoption of IoT will improve the treatment of asthma and COPD, thereby increasing demand.

Furthermore, in order to provide care for the infected population, there is a growing demand for medical supplies. Respiratory support devices like atomizers, oxygen generators, life-support machines, and monitors are some of the most frequently utilized medical devices in primary medical care. The continuous outbreak of the COVID-19 pandemic had a positive effect on the medical device industry. It affects the market for digital dose inhalation. However, this escalating pandemic affects the supply chain and reduces demand for digital dose inhalation devices, resulting in the temporary shutdown of industries and the announcement of lockdowns by governments in numerous regions.

Additionally, due to concerns about patient data security, it is predicted that the market will expand slowly. Due to a lack of knowledge of the symptoms of COPD and asthma, the vast majority of individuals with respiratory illnesses go undiagnosed and are consequently given the incorrect treatment. This may be a result of patients not being technologically savvy and the payment restrictions. The device's limited availability is another issue that, given the existing circumstance, will have a negative impact on the market for digital dosage inhalers throughout the projection period.

Product Outlook

Based on Product, the market is segmented into metered dose inhaler (MDI) and dry powder inhaler (DPI). In 2022, the metered dose inhaler (MDI) segment held the highest revenue share in the market. This is due to rising healthcare costs and increased respiratory disease cases. Furthermore, consistent technological advancements related to the development of inhalation medication, like mechanistic Pharmacokinetic/Pharmacodynamics (PK/PD) modeling, and nanotechnology-based formulations with high drug loads delivered in smaller dose sizes, are some of the critical factors involved in enhancing the therapeutic efficacy of the medication and influencing the overall market.

Type Outlook

On the basis of type, the market is fragmented into branded medication and generic medication. The generic medication segment garnered the highest revenue share in the market. Frequently, digital inhalers include sensors and connectivity features that monitor and track medication usage. They can log the date, time, and frequency of inhaler use, providing valuable information to patients, healthcare providers, and researchers. A few digital inhalers can be programmed with medication reminders and alerts.

Indication Outlook

By indication, the market is bifurcated into asthma, chronic obstructive pulmonary disease (COPD), and others. In 2022, the chronic obstructive pulmonary disease (COPD) segment dominated the market. The segment is anticipated to dominate over the forecast period due to the global increase in COPD incidence. Tobacco use, air pollution, pollen, chemical vapors, and childhood infections are all causes of COPD. Digital Dose Inhalers aid COPD patients in monitoring their respiratory health and drug adherence, enabling them to manage their illness more effectively.

Regional Outlook

Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA. In 2022, the North America region led the market by generating the highest revenue share. This is due to rigorous research and development efforts, as well as an increased awareness of the high-tech respiratory devices currently available. In addition, an increase in the prevalence of respiratory conditions among children and older people will drive market expansion over the forecast period.

The market research report covers the analysis of key stakeholders of the market. Key companies profiled in the report include Sensirion AG, Teva Pharmaceuticals Industries Ltd., OPKO Health, Inc., Propeller Health (ResMed, Inc.), Novartis AG, AstraZeneca PLC, Glenmark Pharmaceuticals Limited, Beximco Pharmaceuticals Ltd., GlaxoSmithKline PLC and Mundipharma Deutschland GmbH & Co. KG.

Strategies Deployed in Digital Dose Inhaler Market

Jun-2023: Teva Pharmaceutical signed an agreement with Phil, Inc., a patient access platform company. Under this agreement, both companies would make Digihaler products available for prescription utilizing the PhilRx Patient Access Platform. The Digihaler system offered by Teva is a smart inhaler that delivers objective inhaler data to support doctors and patients in asthma management.

Jan-2023: AstraZeneca received FDA approval for Airsupra, a pressurized metered-dose inhaler. The approval in the US is for the as-required treatment or prevention of bronchoconstriction and to decrease the risk of exacerbations in people suffering from Asthma of 18 years or more.

Jun-2022: Glenmark Pharm announced the launch of Indament, a novel fixed-dose combination (FDC) drug. The launched drug would be available in three forms with a fixed dose of Indacaterol 150 mcg and variable doses of Mometasone 80 mcg, 160 mcg and 320 mcg to be taken once daily.

Apr-2022: GlaxoSmithKline Pharmaceuticals rolled out Trelegy Ellipta, the first once-daily single-inhaler triple therapy, for Chronic Obstructive Pulmonary Disease patients. The product is used as a maintenance treatment to avert and relieve symptoms related to Chronic Obstructive Pulmonary Disease for patients of age 18 and above.

Sep-2020: Teva Respiratory, LLC., a U.S. affiliate of Teva Pharmaceutical Industries Ltd., introduced AirDuo Digihaler inhalation powder and ArmonAir Digihaler inhalation powder, the digital maintenance inhalers for patients with asthma. The AirDuo Digiinhaler is utilized to manage symptoms of wheezing in patients and asthma. The ArmonAir Digihaler for the treatment of asthma in patients.

Jul-2020: Teva Respiratory, LLC., a U.S. affiliate of Teva Pharmaceutical Industries Ltd. released ProAir Digihaler Inhalation Powder, the digital rescue inhaler indicated in patients of four years and above. The product is used for the prevention and treatment of bronchospasm who have reversible obstructive airway disease.

Jul-2020: Novartis received approval from European commision for Enerzair® Breezhaler®, including the sensor and app. The Product offers inhalation confirmation, medication reminders, and access to objective data to better help therapeutic decisions.

May-2020: Glenmark Pharmaceuticals Ltd. introduced AIRZ-FF, a Single Inhaler Triple Therapy. The launched product is for Chronic Obstructive Pulmonary Disease with the combination of two bronchodilators, Glycopyrronium & Formoterol, and the inhalation corticosteroid Fluticasone propionate. Furthermore, the AIRZ-FF decreases the risk of Severe attacks and eliminates dependence on multiple inhalers.

May-2020: Propeller Health came into partnership with AstraZeneca, a global pharmaceutical company. This partnership would offer respiratory patients a tool to help control their condition and enhance their medication adherence, a key factor in keeping people out of the hospital. Moreover, Propeller Health got FDA approval for a sensor and app to be used with AstraZeneca's Symbicort inhaler for asthma and COPD.

Scope of the Study

Market Segments covered in the Report:

By Product

  • Metered Dose Inhaler (MDI)
  • Dry Powder Inhaler (DPI)

By Type

  • Branded Medication
  • Generic Medication

By Indication

  • COPD
  • Asthma
  • Others

By Geography

  • North America
    • US
    • Canada
    • Mexico
    • Rest of North America
  • Europe
    • Germany
    • UK
    • France
    • Russia
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Singapore
    • Malaysia
    • Rest of Asia Pacific
  • LAMEA
    • Brazil
    • Argentina
    • UAE
    • Saudi Arabia
    • South Africa
    • Nigeria
    • Rest of LAMEA

Companies Profiled

  • Sensirion AG
  • Teva Pharmaceuticals Industries Ltd.
  • OPKO Health, Inc.
  • Propeller Health (ResMed, Inc.)
  • Novartis AG
  • AstraZeneca PLC
  • Glenmark Pharmaceuticals Limited
  • Beximco Pharmaceuticals Ltd.
  • GlaxoSmithKline PLC
  • Mundipharma Deutschland GmbH & Co. KG

Unique Offerings from KBV Research

  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology

  • 1.1 Market Definition
  • 1.2 Objectives
  • 1.3 Market Scope
  • 1.4 Segmentation
    • 1.4.1 Global Digital Dose Inhaler Market, by Product
    • 1.4.2 Global Digital Dose Inhaler Market, by Type
    • 1.4.3 Global Digital Dose Inhaler Market, by Indication
    • 1.4.4 Global Digital Dose Inhaler Market, by Geography
  • 1.5 Methodology for the research

Chapter 2. Market at a Glance

  • 2.1 Key Highlights

Chapter 3. Market Overview

  • 3.1 Introduction
    • 3.1.1 Overview
      • 3.1.1.1 Market Composition and Scenario
  • 3.2 Key Factors Impacting the Market
    • 3.2.1 Market Drivers
    • 3.2.2 Market Restraints
  • 3.3 Porter's Five Force Analysis

Chapter 4. Strategies Deployed in Digital Dose Inhaler Market

Chapter 5. Global Digital Dose Inhaler Market by Product

  • 5.1 Global Metered Dose Inhaler (MDI) Market by Region
  • 5.2 Global Dry Powder Inhaler (DPI) Market by Region

Chapter 6. Global Digital Dose Inhaler Market by Type

  • 6.1 Global Branded Medication Market by Region
  • 6.2 Global Generic Medication Market by Region

Chapter 7. Global Digital Dose Inhaler Market by Indication

  • 7.1 Global COPD Market by Region
  • 7.2 Global Asthma Market by Region
  • 7.3 Global Others Market by Region

Chapter 8. Global Digital Dose Inhaler Market by Region

  • 8.1 North America Digital Dose Inhaler Market
    • 8.1.1 North America Digital Dose Inhaler Market by Product
      • 8.1.1.1 North America Metered Dose Inhaler (MDI) Market by Country
      • 8.1.1.2 North America Dry Powder Inhaler (DPI) Market by Country
    • 8.1.2 North America Digital Dose Inhaler Market by Type
      • 8.1.2.1 North America Branded Medication Market by Country
      • 8.1.2.2 North America Generic Medication Market by Country
    • 8.1.3 North America Digital Dose Inhaler Market by Indication
      • 8.1.3.1 North America COPD Market by Country
      • 8.1.3.2 North America Asthma Market by Country
      • 8.1.3.3 North America Others Market by Country
    • 8.1.4 North America Digital Dose Inhaler Market by Country
      • 8.1.4.1 US Digital Dose Inhaler Market
        • 8.1.4.1.1 US Digital Dose Inhaler Market by Product
        • 8.1.4.1.2 US Digital Dose Inhaler Market by Type
        • 8.1.4.1.3 US Digital Dose Inhaler Market by Indication
      • 8.1.4.2 Canada Digital Dose Inhaler Market
        • 8.1.4.2.1 Canada Digital Dose Inhaler Market by Product
        • 8.1.4.2.2 Canada Digital Dose Inhaler Market by Type
        • 8.1.4.2.3 Canada Digital Dose Inhaler Market by Indication
      • 8.1.4.3 Mexico Digital Dose Inhaler Market
        • 8.1.4.3.1 Mexico Digital Dose Inhaler Market by Product
        • 8.1.4.3.2 Mexico Digital Dose Inhaler Market by Type
        • 8.1.4.3.3 Mexico Digital Dose Inhaler Market by Indication
      • 8.1.4.4 Rest of North America Digital Dose Inhaler Market
        • 8.1.4.4.1 Rest of North America Digital Dose Inhaler Market by Product
        • 8.1.4.4.2 Rest of North America Digital Dose Inhaler Market by Type
        • 8.1.4.4.3 Rest of North America Digital Dose Inhaler Market by Indication
  • 8.2 Europe Digital Dose Inhaler Market
    • 8.2.1 Europe Digital Dose Inhaler Market by Product
      • 8.2.1.1 Europe Metered Dose Inhaler (MDI) Market by Country
      • 8.2.1.2 Europe Dry Powder Inhaler (DPI) Market by Country
    • 8.2.2 Europe Digital Dose Inhaler Market by Type
      • 8.2.2.1 Europe Branded Medication Market by Country
      • 8.2.2.2 Europe Generic Medication Market by Country
    • 8.2.3 Europe Digital Dose Inhaler Market by Indication
      • 8.2.3.1 Europe COPD Market by Country
      • 8.2.3.2 Europe Asthma Market by Country
      • 8.2.3.3 Europe Others Market by Country
    • 8.2.4 Europe Digital Dose Inhaler Market by Country
      • 8.2.4.1 Germany Digital Dose Inhaler Market
        • 8.2.4.1.1 Germany Digital Dose Inhaler Market by Product
        • 8.2.4.1.2 Germany Digital Dose Inhaler Market by Type
        • 8.2.4.1.3 Germany Digital Dose Inhaler Market by Indication
      • 8.2.4.2 UK Digital Dose Inhaler Market
        • 8.2.4.2.1 UK Digital Dose Inhaler Market by Product
        • 8.2.4.2.2 UK Digital Dose Inhaler Market by Type
        • 8.2.4.2.3 UK Digital Dose Inhaler Market by Indication
      • 8.2.4.3 France Digital Dose Inhaler Market
        • 8.2.4.3.1 France Digital Dose Inhaler Market by Product
        • 8.2.4.3.2 France Digital Dose Inhaler Market by Type
        • 8.2.4.3.3 France Digital Dose Inhaler Market by Indication
      • 8.2.4.4 Russia Digital Dose Inhaler Market
        • 8.2.4.4.1 Russia Digital Dose Inhaler Market by Product
        • 8.2.4.4.2 Russia Digital Dose Inhaler Market by Type
        • 8.2.4.4.3 Russia Digital Dose Inhaler Market by Indication
      • 8.2.4.5 Spain Digital Dose Inhaler Market
        • 8.2.4.5.1 Spain Digital Dose Inhaler Market by Product
        • 8.2.4.5.2 Spain Digital Dose Inhaler Market by Type
        • 8.2.4.5.3 Spain Digital Dose Inhaler Market by Indication
      • 8.2.4.6 Italy Digital Dose Inhaler Market
        • 8.2.4.6.1 Italy Digital Dose Inhaler Market by Product
        • 8.2.4.6.2 Italy Digital Dose Inhaler Market by Type
        • 8.2.4.6.3 Italy Digital Dose Inhaler Market by Indication
      • 8.2.4.7 Rest of Europe Digital Dose Inhaler Market
        • 8.2.4.7.1 Rest of Europe Digital Dose Inhaler Market by Product
        • 8.2.4.7.2 Rest of Europe Digital Dose Inhaler Market by Type
        • 8.2.4.7.3 Rest of Europe Digital Dose Inhaler Market by Indication
  • 8.3 Asia Pacific Digital Dose Inhaler Market
    • 8.3.1 Asia Pacific Digital Dose Inhaler Market by Product
      • 8.3.1.1 Asia Pacific Metered Dose Inhaler (MDI) Market by Country
      • 8.3.1.2 Asia Pacific Dry Powder Inhaler (DPI) Market by Country
    • 8.3.2 Asia Pacific Digital Dose Inhaler Market by Type
      • 8.3.2.1 Asia Pacific Branded Medication Market by Country
      • 8.3.2.2 Asia Pacific Generic Medication Market by Country
    • 8.3.3 Asia Pacific Digital Dose Inhaler Market by Indication
      • 8.3.3.1 Asia Pacific COPD Market by Country
      • 8.3.3.2 Asia Pacific Asthma Market by Country
      • 8.3.3.3 Asia Pacific Others Market by Country
    • 8.3.4 Asia Pacific Digital Dose Inhaler Market by Country
      • 8.3.4.1 China Digital Dose Inhaler Market
        • 8.3.4.1.1 China Digital Dose Inhaler Market by Product
        • 8.3.4.1.2 China Digital Dose Inhaler Market by Type
        • 8.3.4.1.3 China Digital Dose Inhaler Market by Indication
      • 8.3.4.2 Japan Digital Dose Inhaler Market
        • 8.3.4.2.1 Japan Digital Dose Inhaler Market by Product
        • 8.3.4.2.2 Japan Digital Dose Inhaler Market by Type
        • 8.3.4.2.3 Japan Digital Dose Inhaler Market by Indication
      • 8.3.4.3 India Digital Dose Inhaler Market
        • 8.3.4.3.1 India Digital Dose Inhaler Market by Product
        • 8.3.4.3.2 India Digital Dose Inhaler Market by Type
        • 8.3.4.3.3 India Digital Dose Inhaler Market by Indication
      • 8.3.4.4 South Korea Digital Dose Inhaler Market
        • 8.3.4.4.1 South Korea Digital Dose Inhaler Market by Product
        • 8.3.4.4.2 South Korea Digital Dose Inhaler Market by Type
        • 8.3.4.4.3 South Korea Digital Dose Inhaler Market by Indication
      • 8.3.4.5 Singapore Digital Dose Inhaler Market
        • 8.3.4.5.1 Singapore Digital Dose Inhaler Market by Product
        • 8.3.4.5.2 Singapore Digital Dose Inhaler Market by Type
        • 8.3.4.5.3 Singapore Digital Dose Inhaler Market by Indication
      • 8.3.4.6 Malaysia Digital Dose Inhaler Market
        • 8.3.4.6.1 Malaysia Digital Dose Inhaler Market by Product
        • 8.3.4.6.2 Malaysia Digital Dose Inhaler Market by Type
        • 8.3.4.6.3 Malaysia Digital Dose Inhaler Market by Indication
      • 8.3.4.7 Rest of Asia Pacific Digital Dose Inhaler Market
        • 8.3.4.7.1 Rest of Asia Pacific Digital Dose Inhaler Market by Product
        • 8.3.4.7.2 Rest of Asia Pacific Digital Dose Inhaler Market by Type
        • 8.3.4.7.3 Rest of Asia Pacific Digital Dose Inhaler Market by Indication
  • 8.4 LAMEA Digital Dose Inhaler Market
    • 8.4.1 LAMEA Digital Dose Inhaler Market by Product
      • 8.4.1.1 LAMEA Metered Dose Inhaler (MDI) Market by Country
      • 8.4.1.2 LAMEA Dry Powder Inhaler (DPI) Market by Country
    • 8.4.2 LAMEA Digital Dose Inhaler Market by Type
      • 8.4.2.1 LAMEA Branded Medication Market by Country
      • 8.4.2.2 LAMEA Generic Medication Market by Country
    • 8.4.3 LAMEA Digital Dose Inhaler Market by Indication
      • 8.4.3.1 LAMEA COPD Market by Country
      • 8.4.3.2 LAMEA Asthma Market by Country
      • 8.4.3.3 LAMEA Others Market by Country
    • 8.4.4 LAMEA Digital Dose Inhaler Market by Country
      • 8.4.4.1 Brazil Digital Dose Inhaler Market
        • 8.4.4.1.1 Brazil Digital Dose Inhaler Market by Product
        • 8.4.4.1.2 Brazil Digital Dose Inhaler Market by Type
        • 8.4.4.1.3 Brazil Digital Dose Inhaler Market by Indication
      • 8.4.4.2 Argentina Digital Dose Inhaler Market
        • 8.4.4.2.1 Argentina Digital Dose Inhaler Market by Product
        • 8.4.4.2.2 Argentina Digital Dose Inhaler Market by Type
        • 8.4.4.2.3 Argentina Digital Dose Inhaler Market by Indication
      • 8.4.4.3 UAE Digital Dose Inhaler Market
        • 8.4.4.3.1 UAE Digital Dose Inhaler Market by Product
        • 8.4.4.3.2 UAE Digital Dose Inhaler Market by Type
        • 8.4.4.3.3 UAE Digital Dose Inhaler Market by Indication
      • 8.4.4.4 Saudi Arabia Digital Dose Inhaler Market
        • 8.4.4.4.1 Saudi Arabia Digital Dose Inhaler Market by Product
        • 8.4.4.4.2 Saudi Arabia Digital Dose Inhaler Market by Type
        • 8.4.4.4.3 Saudi Arabia Digital Dose Inhaler Market by Indication
      • 8.4.4.5 South Africa Digital Dose Inhaler Market
        • 8.4.4.5.1 South Africa Digital Dose Inhaler Market by Product
        • 8.4.4.5.2 South Africa Digital Dose Inhaler Market by Type
        • 8.4.4.5.3 South Africa Digital Dose Inhaler Market by Indication
      • 8.4.4.6 Nigeria Digital Dose Inhaler Market
        • 8.4.4.6.1 Nigeria Digital Dose Inhaler Market by Product
        • 8.4.4.6.2 Nigeria Digital Dose Inhaler Market by Type
        • 8.4.4.6.3 Nigeria Digital Dose Inhaler Market by Indication
      • 8.4.4.7 Rest of LAMEA Digital Dose Inhaler Market
        • 8.4.4.7.1 Rest of LAMEA Digital Dose Inhaler Market by Product
        • 8.4.4.7.2 Rest of LAMEA Digital Dose Inhaler Market by Type
        • 8.4.4.7.3 Rest of LAMEA Digital Dose Inhaler Market by Indication

Chapter 9. Company Profiles

  • 9.1 Sensirion AG
    • 9.1.1 Company Overview
    • 9.1.2 Financial Analysis
    • 9.1.3 Regional Analysis
    • 9.1.4 Research & Development Expenses
    • 9.1.5 SWOT Analysis
  • 9.2 Teva Pharmaceutical Industries Ltd.
    • 9.2.1 Company Overview
    • 9.2.2 Financial Analysis
    • 9.2.3 Regional Analysis
    • 9.2.4 Research & Development Expenses
    • 9.2.5 Recent strategies and developments:
      • 9.2.5.1 Partnerships, Collaborations, and Agreements:
      • 9.2.5.2 Product Launches and Product Expansions:
    • 9.2.6 SWOT Analysis
  • 9.3 OPKO Health, Inc.
    • 9.3.1 Company Overview
    • 9.3.2 Financial Analysis
    • 9.3.3 Segmental and Regional Analysis
    • 9.3.4 Research & Development Expenses
    • 9.3.5 SWOT Analysis
  • 9.4 Propeller Health (ResMed, Inc.)
    • 9.4.1 Company Overview
    • 9.4.2 Financial Analysis
    • 9.4.3 Segmental and Regional Analysis
    • 9.4.4 Research & Development Expenses
    • 9.4.5 Recent strategies and developments:
      • 9.4.5.1 Partnerships, Collaborations, and Agreements:
    • 9.4.6 SWOT Analysis
  • 9.5 Novartis AG
    • 9.5.1 Company Overview
    • 9.5.2 Financial Analysis
    • 9.5.3 Segmental and Regional Analysis
    • 9.5.4 Research & Development Expense
    • 9.5.5 Recent strategies and developments:
      • 9.5.5.1 Approvals and Trials:
    • 9.5.6 SWOT Analysis
  • 9.6 AstraZeneca PLC
    • 9.6.1 Company Overview
    • 9.6.2 Financial Analysis
    • 9.6.3 Regional Analysis
    • 9.6.4 Research & Development Expenses
    • 9.6.5 Recent strategies and developments:
      • 9.6.5.1 Approvals and Trials:
    • 9.6.6 SWOT Analysis
  • 9.7 Glenmark Pharmaceuticals Limited
    • 9.7.1 Company Overview
    • 9.7.2 Financial Analysis
    • 9.7.3 Regional Analysis
    • 9.7.4 Research & Development Expenses
    • 9.7.5 Recent strategies and developments:
      • 9.7.5.1 Product Launches and Product Expansions:
    • 9.7.6 SWOT Analysis
  • 9.8 Beximco Pharmaceuticals Ltd.
    • 9.8.1 Company Overview
    • 9.8.2 Financial Analysis
    • 9.8.3 Research & Development Expenses
    • 9.8.4 SWOT Analysis
  • 9.9 GlaxoSmithKline PLC (GSK)
    • 9.9.1 Company Overview
    • 9.9.2 Financial Analysis
    • 9.9.3 Regional Analysis
    • 9.9.4 Research & Development Expense
    • 9.9.5 Recent strategies and developments:
      • 9.9.5.1 Product Launches and Product Expansions:
    • 9.9.6 SWOT Analysis
  • 9.10. Mundipharma Deutschland GmbH & Co. KG
    • 9.10.1 Company Overview
    • 9.10.2 SWOT Analysis

Chapter 10. Winning Imperative for Digital Dose Inhaler Market